Ryan Freidberg

[Ryan Freidberg @RFreidberg]

@zerohedge Peace talks resume Sunday morning at 5pm. Deal imminent.

[Ryan Freidberg @RFreidberg]

@2000STOCKMASTER I NEED $100, NOT $40!

[Ryan Freidberg @RFreidberg]

@2000STOCKMASTER Lol 😂

[Ryan Freidberg @RFreidberg]

@TheBronxViking @elonmusk Perfectly said

[Ryan Freidberg @RFreidberg]

@Vanhove_Pieter @bioinvestor24 @josedgs28 Have to hang your hat on something when everything else isn’t panning out.

[Ryan Freidberg @RFreidberg]

@MAGAShagster @AndyBradley93 lol if only

[Ryan Freidberg @RFreidberg]

@epictrades1 Yes

[Ryan Freidberg @RFreidberg]

@mikealfred Oh no! you’re a chart squiggler now lol

[Ryan Freidberg @RFreidberg]

@prosperousguy @breakoutchrts Plus some time to compile & package the data. Could be into October

[Ryan Freidberg @RFreidberg]

@brett331_b @ericjackson Yes

[Ryan Freidberg @RFreidberg]

@epictrades1 😳🤣

[Ryan Freidberg @RFreidberg]

@jambal_hot @MeadowCapital @WallStSai No, not without major additional cash raises which would have diluted the stock/gave it more downward pressure

[Ryan Freidberg @RFreidberg]

@FightingbackHD @5waps @ToddAultIII @SECGov @FINRA 1000%

[Ryan Freidberg @RFreidberg]

@epictrades1 All too often

[Ryan Freidberg @RFreidberg]

@aleabitoreddit Short term exit liquidity

[Ryan Freidberg @RFreidberg]

@MeadowCapital Peptide experiments are all the rage right now. I’m surprised the FDA hasn’t clamped down on it yet. Just a matter of time imo

[Ryan Freidberg @RFreidberg]

@epictrades1 $25.60 in overnight trading. Time to size up?

[Ryan Freidberg @RFreidberg]

@CryptoParadyme Dyme, thanks for the reflection and write up. Well said.

[Ryan Freidberg @RFreidberg]

@Braczyy @boq89 Thank you for narrative/trade walkthrough along the way. Anyone who thinks you were trying to call a top is either ignorant or naive. Appreciate all your commentary

[Ryan Freidberg @RFreidberg]

@MichaelEWebber @ERCOT_ISO Lets hear about bitcoin miner curtailment. I bet that’s the real story that should be told. Grid stabilization is a benefit that is not discussed enough.